Moreover, pharmacological reduction of JNK activity not only shifted Smad3 signaling from oncogenesis to tumor-suppression but also inhibited cell proliferation in MUC1-overexpressing HCC cells. This evidence concerns the gene MAPK8 and hepatocellular carcinoma.